Edward Vitkin

Dr. Edward Vitkin

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2012 in Genome Biology
Verified
Journal Article
Open access
PDF file
EVEdward Vitkin
Edward Vitkin
TSTomer Shlomi
Tomer Shlomi
Genome-scale metabolic network reconstructions are considered a key step in quantifying the genotype-phenotype relationship. We present a novel gap-filling approach, MetabolIc Reconstruction via functionAl GEnomics (MIRAGE), which identifies missing network reactions by integrating metabolic flux analysis and functional genomics data. MIRAGE's performance is demonstrated on the reconstruction of metabolic network models of E. coli and Synechocystis sp. and validated via existing networks for these species. Then, it is applied to reconstruct genome-scale metabolic network models for 36 sequenced cyanobacteria amenable for constraint-based modeling analysis and specifically for metabolic engineering. The reconstructed network models are supplied via standard SBML files.

19 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IGIlai Genish
Ilai Genish
BGBatel Gabay
Batel Gabay
ARAngela Ruban
Angela Ruban
YGYona Goldshmit
Yona Goldshmit
ASAmrita Singh
Amrita Singh
AGAlexander Golberg
Alexander Golberg
A major concern in tissue biopsies with a needle is missing the most lethal clone of a tumor, leading to a false negative result. This concern is well justified, since needle-based biopsies gather tissue information limited to needle size. In this work, we show that molecular harvesting with electroporation, e-biopsy, could increase the sampled tissue volume in comparison to tissue sampling by a needle alone. Suggested by numerical models of electric fields distribution, the increased sampled volume is achieved by electroporation-driven permeabilization of cellular membranes in the tissue around the sampling needle. We show that proteomic profiles, sampled by e-biopsy from the brain tissue, ex vivo, at 0.5mm distance outside the visible margins of mice brain melanoma metastasis, have protein patterns similar to melanoma tumor center and different from the healthy brain tissue. In addition, we show that e-biopsy probed proteome signature differentiates between melanoma tumor center and healthy brain in mice. This study suggests that e-biopsy could provide a novel tool for a minimally invasive sampling of molecules in tissue in larger volumes than achieved with traditional needle biopsies.

16 January 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EVEdward Vitkin
Edward Vitkin
AGAmichai Gillis
Amichai Gillis
MPMark Polikovsky
Mark Polikovsky
BBBarak Bender
Barak Bender
AGAlexander Golberg
Alexander Golberg
ZYZohar Yakhini
Zohar Yakhini
Intelligent biorefinery design that addresses both the composition of the biomass feedstock as well as fermentation microorganisms could benefit from dedicated tools for computational simulation and computer-assisted optimization. Here we present the BioLego Vn2.0 framework, based on Microsoft Azure Cloud, which supports large-scale simulations of biomass serial fermentation processes by two different organisms. BioLego enables the simultaneous analysis of multiple fermentation scenarios and the comparison of fermentation potential of multiple feedstock compositions. Thanks to the effective use of cloud computing it further allows resource intensive analysis and exploration of media and organism modifications. We use BioLego to obtain biological and validation results, including (1) exploratory search for the optimal utilization of corn biomasses—corn cobs, corn fiber and corn stover—in fermentation biorefineries; (2) analysis of the possible effects of changes in the composition of K. alvarezi biomass on the ethanol production yield in an anaerobic two-step process (S. cerevisiae followed by E. coli); (3) analysis of the impact, on the estimated ethanol production yield, of knocking out single organism reactions either in one or in both organisms in an anaerobic two-step fermentation process of Ulva sp. into ethanol (S. cerevisiae followed by E. coli); and (4) comparison of several experimentally measured ethanol fermentation rates with the predictions of BioLego.

9 May 2024 in Skin Research and Technology
Verified
Journal Article
Open access
LLLeetal Louie
Leetal Louie
JWJulia Wise
Julia Wise
ABAriel Berl
Ariel Berl
OSOfir Shir‐Az
Ofir Shir‐Az
VKVladimir Kravtsov
Vladimir Kravtsov
EVEdward Vitkin
Edward Vitkin
Background: The incidence rates of cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC) skin cancers are rising, while the current diagnostic process is time‐consuming. We describe the development of a novel approach to high‐throughput sampling of tissue lipids using electroporation‐based biopsy, termed e‐biopsy. We report on the ability of the e‐biopsy technique to harvest large amounts of lipids from human skin samples. Materials and Methods: Here, 168 lipids were reliably identified from 12 patients providing a total of 13 samples. The extracted lipids were profiled with ultra‐performance liquid chromatography and tandem mass spectrometry (UPLC‐MS‐MS) providing cSCC, BCC, and healthy skin lipidomic profiles. Results: Comparative analysis identified 27 differentially expressed lipids ( p < 0.05). The general profile trend is low diglycerides in both cSCC and BCC, high phospholipids in BCC, and high lyso‐phospholipids in cSCC compared to healthy skin tissue samples. Conclusion: The results contribute to the growing body of knowledge that can potentially lead to novel insights into these skin cancers and demonstrate the potential of the e‐biopsy technique for the analysis of lipidomic profiles of human skin tissues.

10 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAriel Berl
Ariel Berl
OSOfir Shir-Az
Ofir Shir-Az
IGIlai Genish
Ilai Genish
HBHadas Biran
Hadas Biran
DMDin Mann
Din Mann
ASAvshalom Shalom
Avshalom Shalom
Basal cell carcinoma (BCC) is the most common type of skin cancer. Due to multiple, potential underlying molecular tumor aberrations, clinical treatment protocols are not well-defined. This study presents multisite molecular heterogeneity profiles of human BCC based on RNA and proteome profiling. Three areas from lesions excised from 9 patients were analyzed. The focus was gene expression profiles based on proteome and RNA measurements of intra-tumor heterogeneity from the same patient and inter-tumor heterogeneity in nodular, infiltrative, and superficial BCC tumor subtypes from different patients. We observed significant overlap in intra- and inter-tumor variability of proteome and RNA expression profiles, showing significant multisite heterogeneity of protein expression in the BCC tumors. Inter-subtype analysis has also identified unique proteins for each BCC subtype. This profiling leads to a deeper understanding of BCC molecular heterogeneity and potentially contributes to developing new sampling tools for personalized diagnostics therapeutic approaches to BCC.

4 March 2024 in Open Research Europe
Verified
Journal Article
Open access
EVEdward Vitkin
Edward Vitkin
Differential expression analysis of biomarker measurements in two conditions is a basic step in understanding the relevance of the selected molecule to the difference between these conditions. In cases, when the biomarker of interest can disappear completely in some of the tested samples, it can be beneficial to replace the quantitative measurements with a simple binary appearance indicator. Standard differential expression approaches, working on quantitative measurements and addressing non-existing molecules as measured with zero intensity, are designed to evaluate the change between low- and high-expression molecules, and therefore not suited well for the evaluation between existing and non-existing molecules. Here we propose two approaches to compare such binary appearance patterns in two independent groups: (i) proportion-based test and (ii) hypergeometric-distribution based test. The first leverages the fact that population proportion behaves according to the normal distribution, while the second reduces the comparison problem to the test of significance of the intersection size between two groups. We demonstrate the value of the suggested binary differential expression analysis methods by investigating (i) proteomic profiles obtained from samples extracted with ebiopsy technique and (ii) transcriptomic profiles obtained from samples extracted with standard biopsy from basal cell carcinoma and squamous cell carcinoma lesions and discuss the results with respect to raw-measurement data based differential expression test of the raw measured intensities.